Diffusion-weighted magnetic resonance imaging of lung cancer at 3.0 T: A preliminary study on monitoring diffusion changes during chemoradiation therapy

Clinical Imaging

Volumn 36, Issue 2, 2012, Pages 98-103

  Chang, Qing ^a   Wu, Ning ^a   Ouyang, Han ^a   Huang, Yao ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Apparent diffusion coefficient; Chemoradiation; Diffusion weighted imaging; Lung carcinoma; Magnetic resonance imaging

Indexed keywords

APPARENT DIFFUSION COEFFICIENT; CHEMORADIATION; DIFFUSION WEIGHTED IMAGES; DIFFUSION WEIGHTED IMAGING; DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING; LUNG CANCER; LUNG CARCINOMA; PRE-TREATMENT;

BIOLOGICAL ORGANS; DISEASES; MAGNETIC RESONANCE IMAGING; SURFACE DIFFUSION;

CHEMORADIOTHERAPY;

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GADOLINIUM PENTETATE; PACLITAXEL;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONSTANTS AND COEFFICIENTS; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT RESPONSE;

ADULT; AGED; BIOPSY, NEEDLE; BRONCHOSCOPY; CHEMORADIOTHERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84863126997     PISSN: 08997071     EISSN: 18734499     Source Type: Journal    
DOI: 10.1016/j.clinimag.2011.07.002     Document Type: Article

References (27)

1. Ohno Y, Adachi S, Kono M, Kusumoto M, Motoyama A, Sugimura K Predicting the prognosis of non-small cell lung cancer patient treated with conservative therapy using contrast-enhanced MR imaging. Eur Radiol 2000, 10:1770-1781.
2. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45:228-247.
3. Watanabe H, Kunitoh H, Yamamoto S, Kawasaki S, Inoue A, Hotta K, Shiomi K, Kusumoto M, Sugimura K, Saijo N Effect of the introduction of minimum lesion size on interobserver reproducibility using RECIST guidelines in non-small cell lung cancer patients. Cancer Sci 2006, 97:214-218.
4. Kiessling F, Farhan N, Lichy MP, Vosseler S, Heilmann M, Krix M, Bohlen P, Miller DW, Mueller MM, Semmler W, Fusenig NE, Delorme S Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101. Neoplasia 2004, 6:213-223.
5. 18F-FDG PET in patients with non-small cell lung cancer. J Nucl Med 2007, 48:1592-1598.
6. Wang J, Wu N, Cham MD, Song Y Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. AJR Am J Roentgenol 2009, 193:1090-1096.
7. Hayashida Y, Hirai T, Morishita S, Kitajima M, Murakami R, Korogi Y, Makino K, Nakamura H, Ikushima I, Yamura M, Kochi M, Kuratsu JI, Yamashita Y Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 2006, 27:1419-1425.
8. Hatakenaka M, Soeda H, Yabuuchi H, Matsuo Y, Kamitani T, Oda Y, Tsuneyoshi M, Honda H Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008, 7:23-29.
9. Sorensen AG, Buonanno FS, Gonzalez RG, Schwamm LH, Lev MH, Huang-Hellinger FR, Reese TG, Weisskoff RM, Davis TL, Suwanwela N, Can U, Moreira JA, Copen WA, Look RB, Finklestein SP, Rosen BR, Koroshetz WJ Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar imaging. Radiology 1996, 199:391-401.
10. Wendland MF, Faustino J, West T, Manabat C, Holtzman DM, Vexler ZS Early diffusion-weighted MRI as a predictor of caspase-3 activation after hypoxic-ischemic insult in neonatal rodents. Stroke 2008, 39:1862-1868.
11. Hein PA, Kremser C, Judmaier W, Griebel J, Pfeiffer KP, Kreczy A, Hug EB, Lukas P, DeVries AF Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 2003, 45:214-222.
12. Provenzale JM, McGraw P, Mhatre P, Guo AC, Delong D Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 2004, 232:451-460.
13. Kim HJ, Choi CG, Lee DH, Lee JH, Kim SJ, Suh DC High-b-value diffusion-weighted MR imaging of hyperacute ischemic stroke at 1.5T. AJNR Am J Neuroradiol 2005, 26:208-215.
14. Kim H, Morgan DE, Zeng H, Grizzle WE, Warram JM, Stockard CR, Wang D, Zinn KR Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology 2008, 248:844-851.
15. Sharma U, Danishad KK, Seenu V, Jagannathan NR Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009, 22:104-113.
16. Wang H, Fei B Diffusion-weighted MRI for monitoring tumor response to photodynamic therapy. J Magn Reson Imaging. 2010, 32:409-417.
17. Wang J, Takashima S, Kawakami S, Kawakami S, Saito A, Matsushita T, Momose M, Ishiyama T Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001, 220:621-630.
18. Müller MF, Prasad P, Siewert B, Nissenbaum MA, Raptopoulos V, Edelman RR Abdominal diffusion mapping with use of a whole-body echo-planar system. Radiology 1994, 190:475-478.
19. Kuhl CK, Gieseke J, von Falkenhausen M, Textor J, Gernert S, Sonntag C, Schild HH Sensitivity encoding for diffusion-weighted MR imaging at 3.0 T: intraindividual comparative study. Radiology 2005, 234:517-526.
20. Koyama H, Ohno Y, Aoyama N, Onishi Y, Matsumoto K, Nogami M, Takenaka D, Nishio W, Ohbayashi C, Sugimura K Comparison of STIR turbo SE imaging and diffusion-weighted imaging of the lung: capability for detection and subtype classification of pulmonary adenocarcinomas. Eur Radiol 2010, 20:790-800.
21. Woodhams R, Matsunaga K, Kan S, Hata H, Ozaki M, Iwabuchi K, Kuranami M, Watanabe M, Hayakawa K ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005, 4:35-42.
22. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003, 226:71-78.
23. Matoba M, Tonami H, Kondou T, Yokota H, Higashi K, Toga H, Sakuma T Lung carcinoma: diffusion-weighted MR imaging-preliminary evaluation with apparent diffusion coefficient. Radiology 2007, 243:570-577.
24. Kim SH, Lee JY, Lee JM, Han JK, Choi BI Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol 2011, 21:987-995.
25. Morse DL, Galons JP, Payne CM, Jennings DL, Day S, Xia G, Gillies RJ MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms. NMR Biomed 2007, 20:602-614.
26. Cao C, Albert JM, Geng L, Ivy PS, Sandler A, Johnson DH, Lu B Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer. Cancer Res 2006, 66:11409-11415.
27. Galons JP, Altbach MI, Paine-Murrieta GD, Taylor CW, Gillies RJ Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1999, 1:113-117.